Methodist celebrating 100th anniversary with Imagine Dragons

When a gun is present in a domestic violence situation, the risk of the woman getting murdered rises by 500 percent. Tell your senators to stand up to the NRA, close the "boyfriend loophole," and reauthorize the Violence Against Women Act. nbcnews.com/politics/congr…

Take your rightful seat in history, Dr. Bouman! 🔭 Congratulations and thank you for your enormous contribution to the advancements of science and mankind. Here’s to #WomenInSTEM! 👩🏻‍🔬👩🏾‍💻👩🏼‍🏭👩🏿‍🏫

Presented our ABTA-funded study “predictable and distinct mechanisms drive de novo vs. acquired resistance to SMO/SHH inhibitors in SHH medulloblastima” at Ped SNO in lovely San Francisco

Thank you ABTA for sponsoring my visit to Massimo Squatrito’s lab in Madrid! It’s been a very productive visit-learning new techniques, setting up new collaborations and working on our manuscript together.

Just learning to tweet 🤪 and apparently did not do this right the first time. Thank you American Brain Tumor Association and Massimo Massimo Squatrito and @CNIO_Cancer for an awesome trip. American Cancer Society

Our June 2019 issue is now live. Read about optimal design of and use of biomarkers in oncology trials, regulatory T cells, resistance to CAR T cell therapy and germline alterations in cancer: nature.com/nrclinonc/volu…

Readers aged 18 to 25 can enter Nature’s essay competition. Tell us, in an essay of no more than 1,000 words, what scientific advance, big or small, you would most like to see in your lifetime. Deadline is Aug. 9. More details here: go.nature.com/2WZjJ53

Brain cancer is slightly more common in men than women. To find more quick stats on brain cancer, visit: buff.ly/2IlAAe3 #BTSM

Combination of encorafenib, binimetinib and cetuximab significantly improved overall survival in patients with BRAF-mutated metastatic #colorectalcancer. Our Scott Kopetz to present findings of Phase III BEACON clinical trial at #WorldGI2019: bit.ly/2L5Fm1C #endcancer

As part of #NationalGirlfriendsDay, let's give a shoutout to the friends who always have our backs! My girlfriends aren’t just people I like to hang out with—though we do plenty of that—they’re a vital part of who I am and who I’ll keep becoming.

Great to host a quick visit from Nicole Willmarth Nicole Willmarth, PhD from ABTA @abta at TMC along with other AARN members Betty Kim Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE, Martyn Sharpe Yun lab

Summer science symposium at @HoustonMethodist. Congratulations to our interns Hannah Borland and Taha Ismail for doing a great job this summer! Postdoc Nourhan Abdelfatta presenting her exciting work on medulloblastoma immune regulation.Yun lab

Congratulations to our postdoc Nourhan for winning second place for her poster on sex biased medulloblastoma immune regulation! Yun lab @houstonmethodist

Over the years I dabbled in different areas of immunology & virology. Some areas are filled with people who support each other's work while other areas are so cliquey and impenetrable. Science benefits when ideas come from ppl with diverse backgrounds. Let's welcome newcomers.

A year ago today I was unable to walk having suffered a stroke. Thanks to the mindset learned as an Olympian, 2 months later I was back running! Today I’m thankful to my family, friends, fans, and MJ Performance for the incredible support! #strokesurvivor #health #Olympics #motivation

Great team building event with the American Brain Tumor Association #AARN2019 meeting orange team at Dave and busters #DNBTeamBuilding

Thank you!

I am so utterly and deeply sorry to hear this news. My thoughts, strength and prayers are with the Duncan family and all his friends and loved ones. What a tragedy. Glioblastoma (like all cancer) is pure, unadulterated evil. We must keep striving for a cure for it.

With co-PIs Ueno Naoto T Ueno, MD, PhD and Yun Yun lab our R01-funded tri-group study will test the accuracy of #EMPIRI E-slices to predict #TNBC patient response to standard of care therapies, including #immunotherapy (#pembro). #Breastcancer